- Home
- OVV vs TECH Comparison
OVV vs TECH Comparison
Compare OVV & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVV
- TECH
- Stock Information
- Founded
- OVV 2020
- TECH 1976
- Country
- OVV United States
- TECH United States
- Employees
- OVV N/A
- TECH N/A
- Industry
- OVV Oil & Gas Production
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OVV Energy
- TECH Health Care
- Exchange
- OVV Nasdaq
- TECH Nasdaq
- Market Cap
- OVV 11.4B
- TECH 11.3B
- IPO Year
- OVV N/A
- TECH 1989
- Fundamental
- Price
- OVV $45.75
- TECH $68.72
- Analyst Decision
- OVV Buy
- TECH Buy
- Analyst Count
- OVV 16
- TECH 9
- Target Price
- OVV $56.40
- TECH $81.78
- AVG Volume (30 Days)
- OVV 2.9M
- TECH 1.2M
- Earning Date
- OVV 11-07-2024
- TECH 10-30-2024
- Dividend Yield
- OVV 2.62%
- TECH 0.47%
- EPS Growth
- OVV N/A
- TECH N/A
- EPS
- OVV 7.54
- TECH 0.95
- Revenue
- OVV $9,562,000,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- OVV N/A
- TECH $7.67
- Revenue Next Year
- OVV N/A
- TECH $9.38
- P/E Ratio
- OVV $6.05
- TECH $72.05
- Revenue Growth
- OVV N/A
- TECH 2.41
- 52 Week Low
- OVV $36.91
- TECH $61.16
- 52 Week High
- OVV $55.95
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- OVV 66.46
- TECH 41.02
- Support Level
- OVV $44.29
- TECH $65.99
- Resistance Level
- OVV $45.29
- TECH $76.43
- Average True Range (ATR)
- OVV 1.28
- TECH 2.71
- MACD
- OVV 0.50
- TECH -0.85
- Stochastic Oscillator
- OVV 98.25
- TECH 19.25
About OVV Ovintiv Inc. (DE)
Ovintiv is a North American oil and natural gas exploration and production company. It focuses on the exploration and development of oil, NGLs, and natural gas reserves. The company has three segments: USA Operations, Canadian Operations, and Market Optimization.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.